The FDA gave Naviswiss FDA clearance for its navigation technology for hip replacement surgery, allowing the company to begin selling its products in all U.S. markets.
The clearance is for both primary replacement and revision hip replacement surgery. The technology works with several surgical approaches and available implants on the market.
Naviswiss now offers its products in the U.S., Europe, Australia and Asia.